Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

This study is currently recruiting participants.

Verified June 2012 by University of Medicine and Dentistry New Jersey

Study NCT01006369 Information provided by University of Medicine and Dentistry New Jersey

First Received on October 30, 2009. Last Updated on June 12, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Colorectal Cancer

Additional conditions recognized in this trial

Colorectal Neoplasms

More general conditions related to this trial

Interventions listed in this trial

bevacizumab
XELOX regimen
hydroxychloroquine

Additional drug interventions recognized in this trial

Capecitabine
Oxaliplatin

More general drug interventions related to this trial

Sponsors listed in this trial